Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 384

1.

The updated EAU guidelines on muscle-invasive and metastatic bladder cancer.

Stenzl A, Cowan NC, De Santis M, Jakse G, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA.

Eur Urol. 2009 Apr;55(4):815-25. doi: 10.1016/j.eururo.2009.01.002. Epub 2009 Jan 13. Review.

PMID:
19157687
2.

[Update of the Clinical Guidelines of the European Association of Urology on muscle-invasive and metastatic bladder carcinoma].

Stenzl A, Cowan NC, De Santis M, Jakse G, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA; European Association of Urology.

Actas Urol Esp. 2010 Jan;34(1):51-62. Spanish.

PMID:
20223133
3.

Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.

Stenzl A, Cowan NC, De Santis M, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA; European Association of Urology (EAU).

Eur Urol. 2011 Jun;59(6):1009-18. doi: 10.1016/j.eururo.2011.03.023. Epub 2011 Mar 23. Review.

PMID:
21454009
4.

[Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines].

Stenzl A, Cowan NC, De Santis M, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA; European Association of Urology.

Actas Urol Esp. 2012 Sep;36(8):449-60. Epub 2012 Mar 2. Spanish.

PMID:
22386114
5.

EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.

Witjes JA, Compérat E, Cowan NC, De Santis M, Gakis G, Lebret T, Ribal MJ, Van der Heijden AG, Sherif A; European Association of Urology.

Eur Urol. 2014 Apr;65(4):778-92. doi: 10.1016/j.eururo.2013.11.046. Epub 2013 Dec 12.

PMID:
24373477
6.

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.

Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J; European Association of Urology (EAU).

Eur Urol. 2008 Aug;54(2):303-14. doi: 10.1016/j.eururo.2008.04.051. Epub 2008 Apr 30. Review.

PMID:
18468779
7.

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.

Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Compérat E, Sylvester RJ, Kaasinen E, Böhle A, Palou Redorta J, Rouprêt M; European Association of Urology.

Eur Urol. 2013 Oct;64(4):639-53. doi: 10.1016/j.eururo.2013.06.003. Epub 2013 Jun 12. Review.

PMID:
23827737
8.

European Association of Urology guidelines on Male Infertility: the 2012 update.

Jungwirth A, Giwercman A, Tournaye H, Diemer T, Kopa Z, Dohle G, Krausz C; European Association of Urology Working Group on Male Infertility.

Eur Urol. 2012 Aug;62(2):324-32. doi: 10.1016/j.eururo.2012.04.048. Epub 2012 May 3.

PMID:
22591628
9.

Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.

Sternberg CN, Donat SM, Bellmunt J, Millikan RE, Stadler W, De Mulder P, Sherif A, von der Maase H, Tsukamoto T, Soloway MS.

Urology. 2007 Jan;69(1 Suppl):62-79. Review.

PMID:
17280909
10.

An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer.

Kulkarni GS, Hakenberg OW, Gschwend JE, Thalmann G, Kassouf W, Kamat A, Zlotta A.

Eur Urol. 2010 Jan;57(1):60-70. doi: 10.1016/j.eururo.2009.08.024. Epub 2009 Sep 1. Review.

PMID:
19740595
11.

SEOM clinical guidelines for the treatment of invasive bladder cancer.

Morales R, Font A, Carles J, Isla D.

Clin Transl Oncol. 2011 Aug;13(8):552-9. doi: 10.1007/s12094-011-0696-8.

PMID:
21821489
12.

[EAU guidelines on non-muscle-carcinoma of the bladder].

Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J; Asociación Europea de Urología.

Actas Urol Esp. 2009 Apr;33(4):361-71. Review. Spanish.

PMID:
19579886
13.

[EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update].

Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J, Rouprêt M; Asociación Europea de Urología.

Actas Urol Esp. 2012 Jul-Aug;36(7):389-402. doi: 10.1016/j.acuro.2011.12.001. Epub 2012 Mar 2. Spanish.

PMID:
22386115
14.

SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016).

Lázaro M, Gallardo E, Doménech M, Pinto Á, Del Alba AG, Puente J, Fernández O, Font A, Lainez N, Vázquez S.

Clin Transl Oncol. 2016 Dec;18(12):1197-1205. Epub 2016 Nov 29.

15.

[European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract].

Rouprêt M, Zigeuner R, Palou J, Boehle A, Kaasinen E, Sylvester R, Babjuk M, Oosterlinck W; European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract.

Actas Urol Esp. 2012 Jan;36(1):2-14. doi: 10.1016/j.acuro.2011.09.001. Epub 2011 Oct 29. Spanish.

PMID:
22036956
16.

Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy.

van Rhijn BW, Burger M, Lotan Y, Solsona E, Stief CG, Sylvester RJ, Witjes JA, Zlotta AR.

Eur Urol. 2009 Sep;56(3):430-42. doi: 10.1016/j.eururo.2009.06.028. Epub 2009 Jun 26. Review.

PMID:
19576682
17.

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update.

Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J, Rouprêt M; European Association of Urology (EAU).

Eur Urol. 2011 Jun;59(6):997-1008. doi: 10.1016/j.eururo.2011.03.017. Epub 2011 Mar 22. Review.

PMID:
21458150
18.

A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group.

Brausi M, Witjes JA, Lamm D, Persad R, Palou J, Colombel M, Buckley R, Soloway M, Akaza H, Böhle A.

J Urol. 2011 Dec;186(6):2158-67. doi: 10.1016/j.juro.2011.07.076. Epub 2011 Oct 19. Review.

PMID:
22014799
19.

Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.

Muramaki M, Miyake H, Kurahashi T, Takenaka A, Inoue TA, Fujisawa M.

Int J Urol. 2008 Apr;15(4):314-8. doi: 10.1111/j.1442-2042.2008.02000.x.

20.

Guidelines on bladder cancer.

Oosterlinck W, Lobel B, Jakse G, Malmström PU, Stöckle M, Sternberg C; European Association of Urology (EAU) Working Group on Oncological Urology.

Eur Urol. 2002 Feb;41(2):105-12. Review.

PMID:
12074395

Supplemental Content

Support Center